Metabolic & Heart

·

Review

Reishi and Poria Triterpenoids Target Type 2 Diabetes

Reishi and Poria Triterpenoids Target Type 2 Diabetes

Reishi, Poria

What they found

A review shows mushroom triterpenoids improve insulin sensitivity and reduce post-meal blood sugar spikes and inflammation.

A review shows mushroom triterpenoids improve insulin sensitivity and reduce post-meal blood sugar spikes and inflammation.

How solid is it?

Review

Review

Narrative review

Narrative review

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Ganoderma lucidum, Wolfiporia extensa

Ganoderma lucidum, Wolfiporia extensa

Compound

triterpenoids

triterpenoids

Published in

Phytotherapy Research : PTR

Phytotherapy Research : PTR

Covered in Shroom Scan

Section

HEALTH & WELLNESS

HEALTH & WELLNESS

As it ran in Shroom Scan

Diabetes Defense

Diabetes Defense

Triterpenoids—natural compounds found in mushrooms like reishi (Ganoderma lucidum) and poria (Wolfiporia extensa)—target the root causes of type 2 diabetes. This critical review shows how they improve insulin sensitivity, reduce post-meal blood sugar spikes, and lower inflammation and oxidative stress.

Triterpenoids—natural compounds found in mushrooms like reishi (Ganoderma lucidum) and poria (Wolfiporia extensa)—target the root causes of type 2 diabetes. This critical review shows how they improve insulin sensitivity, reduce post-meal blood sugar spikes, and lower inflammation and oxidative stress.

Ozempic-Like Mushrooms, Brain-Healing Lion’s Mane, and One-Dose OCD Relief

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.